A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Year: 2009
Type: article
Source: Nature Medicine
DOI: 10.1038/nm.1908
Authors: Pierre Farmer, Hervé Bonnefoi, Pascale Anderle, David Cameron, Pratyakasha Wirapati, Véronique Becette, Sylvie André, Martine Piccart, Mario Campone, Etienne Brain, Gaëtan MacGrogan, Thierry Petit, Jacek Jassem, Frédéric Bibeau, Emmanuel Blot, Jan Bogaerts, Michel Aguet, Jonas Bergh, Richard Iggo, Mauro Delorenzi
Institutions: SIB Swiss Institute of Bioinformatics, École Polytechnique Fédérale de Lausanne, Merck Serono S.p.A. (Italy), European Organisation for Research and Treatment of Cancer, Université de Bordeaux, Inserm, University Hospital of Geneva, European Organisation for Research and Treatment of Cancer, Institut Bergonié, Swiss Group For Clinical Cancer Research, Istituto Oncologico della Svizzera Italiana, Western General Hospital, Hôpital René Huguenin, Institut Jules Bordet, Institut Strauss, Gdańsk Medical University, Centre Henri Becquerel, Karolinska University Hospital, Karolinska Institutet, University of St Andrews
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2023906705
